Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

CDKN2D Antikörper

Name: CDKN2D Antikörper
SKU: ABIN2326453
Price: 838.39 EUR
Availability: InStock

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CDKN2D in WB, IHC und IC. Er zeigt eine Reaktivität gegenüber Human.

Produktnummer ABIN2326453

Kurzübersicht für CDKN2D Antikörper (ABIN2326453)

Target

Alle CDKN2D Antikörper anzeigen

CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Reaktivität

Human

Wirt

Maus

Klonalität

Monoklonal

Konjugat

Dieser CDKN2D Antikörper ist unkonjugiert

Applikation

Western Blotting (WB), Immunohistochemistry (IHC), Immunochromatography (IC)

Klon

IMD-19

Discover our top product CDKN2D Primärantikörper

Kreuzreaktivität

Human

Kreuzreaktivität (Details)

Calculated cross reactivity: Hu

Produktmerkmale

p19INK4d (INK4D, p19, p19-INK4d)

Aufreinigung

Purified

Immunogen

Recombinant human p19INK4d.

Isotyp

IgG1
anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 15-43), (N-Term) antibody
CDKN2D Reaktivität: Human, Maus WB, IHC (p), FACS Wirt: Kaninchen Polyclonal RB23860 unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 1-166) antibody
CDKN2D Reaktivität: Human WB, ELISA, IP Wirt: Maus Monoclonal 2E10 unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 1-166) antibody
CDKN2D Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 1-166) antibody
CDKN2D Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 1-166) antibody
CDKN2D Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) antibody
CDKN2D Reaktivität: Human WB, IP, IHC (p) Wirt: Maus Monoclonal DCS-100 unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) antibody
CDKN2D Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 15-43) antibody
CDKN2D Reaktivität: Human, Maus WB, IHC, IHC (p), FACS Wirt: Kaninchen Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) (AA 1-166) antibody
CDKN2D Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated

anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) antibody
CDKN2D Reaktivität: Human WB, ELISA, IF, IHC (p), RIA Wirt: Kaninchen Polyclonal DCS-100 unconjugated

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Lyophilized

Rekonstitution

Reconstitution: 1.2 % sodium acetate or neutral PBS. If 1 mL of PBS is used, the antibody concentration will be 100 μg/mL.

Buffer

Ascites, Supplied as a lyophilized powder.

Lagerung

-20 °C

Informationen zur Lagerung

-20°C
Target

CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Andere Bezeichnung

p19INK4d

Pathways

Zellzyklus, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling